Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01DD15	OMNICEF	B	Cefdinir - 125mg/5ml	125mg/5ml	Powder for suspension	1,189,301 L.L
J01DD15	OMNICEF	B	Cefdinir - 125mg/5ml	125mg/5ml	Powder for suspension	2,025,171 L.L
J01DD15	OMNICEF	B	Cefdinir - 125mg/5ml	125mg/5ml	Powder for suspension	2,025,171 L.L
J01DD15	OMNICEF	B	Cefdinir - 125mg/5ml	125mg/5ml	Powder for suspension	1,189,301 L.L
J01DD15	OMNICEF	B	Cefdinir - 250mg/5ml	250mg/5ml	Powder for suspension	3,670,034 L.L
J01DD15	OMNICEF	B	Cefdinir - 300mg	300mg	Capsule	2,238,842 L.L
J01DD15	OMNICEF 300	B	Cefdinir - 300mg	300mg	Capsule	2,238,842 L.L
S02AA30	OTOCOL	G	Chloramphenicol - 50mg/ml, Benzocaine - 50mg/ml		Drops	163,949 L.L
G03GA08	OVITRELLE	BioHuman	Choriogonadotropin Alfa - 250mcg/0.5ml	250mcg/0.5ml	Injectable solution	4,145,754 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 1,000IU	1,000IU	Injectable lyophilised powder for solution+diluent	46,817,511 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	13,247,110 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	26,495,478 L.L
R06AX27	ORADUS	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Solution	199,657 L.L
R06AX	ORADUS BETA	G	Desloratadine - 1mg/ml, Betamethasone - 0.05mg/ml		Solution	639,925 L.L
R06AX27	ORADUS	G	Desloratadine - 5mg	5mg	Tablet, film coated	383,955 L.L
R06AX	ORADUS BETA	G	Desloratadine - 5mg, Betamethasone - 0.6mg		Tablet, film coated	497,862 L.L
S01CA01	OPTIDEX T	G	Dexamethasone - 1mg/ml, Tobramycin - 3mg/ml		Drops suspension	266,081 L.L
S01BA01	OZURDEX	B	Dexamethasone - 700mcg	700mcg	Implant	80,696,540 L.L
S01BA01	OZURDEX	B	Dexamethasone - 700mcg	700mcg	Implant	80,696,540 L.L
M02AA15	OLFEN	G	Diclofenac sodium (diethylamine) - 1%	1%	Gel	268,769 L.L
M01AB05	OLFEN-100 SR	G	Diclofenac sodium - 100mg	100mg	Capsule, prolonged release	503,941 L.L
M01AB05	OLFEN-50	G	Diclofenac sodium - 50mg	50mg	Tablet, gastroresistant	248,611 L.L
M01AB05	OLFEN 75MG	G	Diclofenac sodium - 75mg	75mg	Injectable solution	334,617 L.L
M01AB05	OLFEN-75 SR	G	Diclofenac sodium - 75mg	75mg	Tablet, prolonged release	326,554 L.L
G03CA03	OESTRODOSE	B	Estradiol (17 bêta estradiol anhydre) - 0.06%	0.06%	Gel	642,357 L.L
G03CA03	OESTRACLIN	G	Estradiol - 0.6mg/g	0.6mg/g	Gel	448,843 L.L
M04AA03	OXUBAT 120	G	Febuxostat - 120mg	120mg	Tablet, film coated	1,549,002 L.L
M04AA03	OXUBAT 80	G	Febuxostat - 80mg	80mg	Tablet, film coated	1,549,002 L.L
J02AC01	ORAMAX	G	Fluconazole - 150mg	150mg	Capsule	170,668 L.L
S01BA07	OPTILONE	G	Fluorometholone - 0.1%	0.1%	Solution	309,084 L.L

...